Roche’s combination drug for breast cancer secures EC approval
The chemotherapy is advised for TNBC patients whose tumours have PD-L1 expression and have not received prior chemotherapy…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Aug 19
The chemotherapy is advised for TNBC patients whose tumours have PD-L1 expression and have not received prior chemotherapy…
27 Aug 19
The closing of the transaction is subject to the signing of a consent decree by Bristol-Myers Squibb and…
21 May 19
Twitter announced this week that it plans to present reliable information about vaccines to help combat misconceptions being…
02 Apr 19
The UK pharma industry has called for a temporary medicines export ban to prevent the NHS from being…
02 Apr 19
NHS England now plays a key gatekeeper role for the industry’s high cost specialised medicines, and has become…
25 Feb 19
The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and…
13 Feb 19
A new world-first, digital tracking system covering the medicines supply chain across the EU has gone live, promising…
13 Feb 19
The FDA is cracking down on those selling dietary supplement and has sent warning letters to companies who…
As combination products become more prevalent, they pose a number of regulatory challenges. Essentially, it isn’t always clear…
With regulatory requirements evolving fast, much of the discussion around track and trace revolves around meeting compliance deadlines.…